カテゴリ： 世界, 医療/バイオ, Market Monitor Global

RNA治療学のグローバル市場展望 2023年-2029年：mRNA、RNA干渉（RNAi）、アンチセンスオリゴヌクレオチド（ASO）、その他

■ 英語タイトル：RNA Therapeutics Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14460）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14460
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：100
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[RNA治療学のグローバル市場展望 2023年-2029年：mRNA、RNA干渉（RNAi）、アンチセンスオリゴヌクレオチド（ASO）、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のRNA治療学市場規模と予測を収録しています。・世界のRNA治療学市場：売上、2018年-2023年、2024年-2029年
・世界のRNA治療学市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のRNA治療学市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「mRNA」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

RNA治療学のグローバル主要企業は、Moderna、 Alnylam Pharmaceuticals、 Novartis、 Ionis Pharmaceuticals、 Sarepta Therapeutics、 Sanofi、 Pfizer、 Arrowhead Pharmaceuticals、 BioNTech、 Orna Therapeutics、 CRISPR Therapeutics、 Silence Therapeutics、 Astellas Pharma Inc.、 CureVac、 Sirnaomics、 Arcturus Therapeutics、 Arbutus Biopharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、RNA治療学のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のRNA治療学市場：タイプ別、2018年-2023年、2024年-2029年
世界のRNA治療学市場：タイプ別市場シェア、2022年
・mRNA、RNA干渉（RNAi）、アンチセンスオリゴヌクレオチド（ASO）、その他

世界のRNA治療学市場：用途別、2018年-2023年、2024年-2029年
世界のRNA治療学市場：用途別市場シェア、2022年
・病院、研究機関

世界のRNA治療学市場：地域・国別、2018年-2023年、2024年-2029年
世界のRNA治療学市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるRNA治療学のグローバル売上、2018年-2023年
・主要企業におけるRNA治療学のグローバル売上シェア、2022年
・主要企業におけるRNA治療学のグローバル販売量、2018年-2023年
・主要企業におけるRNA治療学のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Moderna、 Alnylam Pharmaceuticals、 Novartis、 Ionis Pharmaceuticals、 Sarepta Therapeutics、 Sanofi、 Pfizer、 Arrowhead Pharmaceuticals、 BioNTech、 Orna Therapeutics、 CRISPR Therapeutics、 Silence Therapeutics、 Astellas Pharma Inc.、 CureVac、 Sirnaomics、 Arcturus Therapeutics、 Arbutus Biopharma

*************************************************************

・調査・分析レポートの概要
RNA治療学市場の定義
市場セグメント
世界のRNA治療学市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のRNA治療学市場規模
世界のRNA治療学市場規模：2022年 VS 2029年
世界のRNA治療学市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのRNA治療学の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のRNA治療学製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：mRNA、RNA干渉（RNAi）、アンチセンスオリゴヌクレオチド（ASO）、その他
RNA治療学のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、研究機関
RNA治療学の用途別グローバル売上・予測

・地域別市場分析
地域別RNA治療学市場規模 2022年と2029年
地域別RNA治療学売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Moderna、 Alnylam Pharmaceuticals、 Novartis、 Ionis Pharmaceuticals、 Sarepta Therapeutics、 Sanofi、 Pfizer、 Arrowhead Pharmaceuticals、 BioNTech、 Orna Therapeutics、 CRISPR Therapeutics、 Silence Therapeutics、 Astellas Pharma Inc.、 CureVac、 Sirnaomics、 Arcturus Therapeutics、 Arbutus Biopharma
...

This research report provides a comprehensive analysis of the RNA Therapeutics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global RNA Therapeutics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of RNA Therapeutics, challenges faced by the industry, and potential opportunities for market players.
The global RNA Therapeutics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The RNA Therapeutics market presents opportunities for various stakeholders, including Hospitals, Research Institutions. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in RNA Therapeutics market. Additionally, the growing consumer demand present avenues for market expansion.
The global RNA Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the RNA Therapeutics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the RNA Therapeutics market.
Market Overview: The report provides a comprehensive overview of the RNA Therapeutics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., mRNA, RNA Interference (RNAi)), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the RNA Therapeutics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the RNA Therapeutics market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the RNA Therapeutics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the RNA Therapeutics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the RNA Therapeutics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the RNA Therapeutics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for RNA Therapeutics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the RNA Therapeutics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
RNA Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
mRNA
RNA Interference (RNAi)
Antisense Oligonucleotide (ASO)
Other
Market segment by Application
Hospitals
Research Institutions
Global RNA Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Moderna
Alnylam Pharmaceuticals
Novartis
Ionis Pharmaceuticals
Sarepta Therapeutics
Sanofi
Pfizer
Arrowhead Pharmaceuticals
BioNTech
Orna Therapeutics
CRISPR Therapeutics
Silence Therapeutics
Astellas Pharma Inc.
CureVac
Sirnaomics
Arcturus Therapeutics
Arbutus Biopharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of RNA Therapeutics, market overview.
Chapter 2: Global RNA Therapeutics market size in revenue.
Chapter 3: Detailed analysis of RNA Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RNA Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 RNA Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA Therapeutics Overall Market Size
2.1 Global RNA Therapeutics Market Size: 2022 VS 2029
2.2 Global RNA Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNA Therapeutics Players in Global Market
3.2 Top Global RNA Therapeutics Companies Ranked by Revenue
3.3 Global RNA Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 RNA Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies RNA Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNA Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 RNA Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 RNA Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global RNA Therapeutics Market Size Markets, 2022 & 2029
4.1.2 mRNA
4.1.3 RNA Interference (RNAi)
4.1.4 Antisense Oligonucleotide (ASO)
4.1.5 Other
4.2 By Type – Global RNA Therapeutics Revenue & Forecasts
4.2.1 By Type – Global RNA Therapeutics Revenue, 2018-2023
4.2.2 By Type – Global RNA Therapeutics Revenue, 2024-2029
4.2.3 By Type – Global RNA Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global RNA Therapeutics Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Research Institutions
5.2 By Application – Global RNA Therapeutics Revenue & Forecasts
5.2.1 By Application – Global RNA Therapeutics Revenue, 2018-2023
5.2.2 By Application – Global RNA Therapeutics Revenue, 2024-2029
5.2.3 By Application – Global RNA Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global RNA Therapeutics Market Size, 2022 & 2029
6.2 By Region – Global RNA Therapeutics Revenue & Forecasts
6.2.1 By Region – Global RNA Therapeutics Revenue, 2018-2023
6.2.2 By Region – Global RNA Therapeutics Revenue, 2024-2029
6.2.3 By Region – Global RNA Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America RNA Therapeutics Revenue, 2018-2029
6.3.2 US RNA Therapeutics Market Size, 2018-2029
6.3.3 Canada RNA Therapeutics Market Size, 2018-2029
6.3.4 Mexico RNA Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe RNA Therapeutics Revenue, 2018-2029
6.4.2 Germany RNA Therapeutics Market Size, 2018-2029
6.4.3 France RNA Therapeutics Market Size, 2018-2029
6.4.4 U.K. RNA Therapeutics Market Size, 2018-2029
6.4.5 Italy RNA Therapeutics Market Size, 2018-2029
6.4.6 Russia RNA Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries RNA Therapeutics Market Size, 2018-2029
6.4.8 Benelux RNA Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia RNA Therapeutics Revenue, 2018-2029
6.5.2 China RNA Therapeutics Market Size, 2018-2029
6.5.3 Japan RNA Therapeutics Market Size, 2018-2029
6.5.4 South Korea RNA Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia RNA Therapeutics Market Size, 2018-2029
6.5.6 India RNA Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America RNA Therapeutics Revenue, 2018-2029
6.6.2 Brazil RNA Therapeutics Market Size, 2018-2029
6.6.3 Argentina RNA Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa RNA Therapeutics Revenue, 2018-2029
6.7.2 Turkey RNA Therapeutics Market Size, 2018-2029
6.7.3 Israel RNA Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia RNA Therapeutics Market Size, 2018-2029
6.7.5 UAE RNA Therapeutics Market Size, 2018-2029
7 RNA Therapeutics Companies Profiles
7.1 Moderna
7.1.1 Moderna Company Summary
7.1.2 Moderna Business Overview
7.1.3 Moderna RNA Therapeutics Major Product Offerings
7.1.4 Moderna RNA Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Moderna Key News & Latest Developments
7.2 Alnylam Pharmaceuticals
7.2.1 Alnylam Pharmaceuticals Company Summary
7.2.2 Alnylam Pharmaceuticals Business Overview
7.2.3 Alnylam Pharmaceuticals RNA Therapeutics Major Product Offerings
7.2.4 Alnylam Pharmaceuticals RNA Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis RNA Therapeutics Major Product Offerings
7.3.4 Novartis RNA Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Ionis Pharmaceuticals
7.4.1 Ionis Pharmaceuticals Company Summary
7.4.2 Ionis Pharmaceuticals Business Overview
7.4.3 Ionis Pharmaceuticals RNA Therapeutics Major Product Offerings
7.4.4 Ionis Pharmaceuticals RNA Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Ionis Pharmaceuticals Key News & Latest Developments
7.5 Sarepta Therapeutics
7.5.1 Sarepta Therapeutics Company Summary
7.5.2 Sarepta Therapeutics Business Overview
7.5.3 Sarepta Therapeutics RNA Therapeutics Major Product Offerings
7.5.4 Sarepta Therapeutics RNA Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Sarepta Therapeutics Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Company Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi RNA Therapeutics Major Product Offerings
7.6.4 Sanofi RNA Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Sanofi Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer RNA Therapeutics Major Product Offerings
7.7.4 Pfizer RNA Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Arrowhead Pharmaceuticals
7.8.1 Arrowhead Pharmaceuticals Company Summary
7.8.2 Arrowhead Pharmaceuticals Business Overview
7.8.3 Arrowhead Pharmaceuticals RNA Therapeutics Major Product Offerings
7.8.4 Arrowhead Pharmaceuticals RNA Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Arrowhead Pharmaceuticals Key News & Latest Developments
7.9 BioNTech
7.9.1 BioNTech Company Summary
7.9.2 BioNTech Business Overview
7.9.3 BioNTech RNA Therapeutics Major Product Offerings
7.9.4 BioNTech RNA Therapeutics Revenue in Global Market (2018-2023)
7.9.5 BioNTech Key News & Latest Developments
7.10 Orna Therapeutics
7.10.1 Orna Therapeutics Company Summary
7.10.2 Orna Therapeutics Business Overview
7.10.3 Orna Therapeutics RNA Therapeutics Major Product Offerings
7.10.4 Orna Therapeutics RNA Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Orna Therapeutics Key News & Latest Developments
7.11 CRISPR Therapeutics
7.11.1 CRISPR Therapeutics Company Summary
7.11.2 CRISPR Therapeutics Business Overview
7.11.3 CRISPR Therapeutics RNA Therapeutics Major Product Offerings
7.11.4 CRISPR Therapeutics RNA Therapeutics Revenue in Global Market (2018-2023)
7.11.5 CRISPR Therapeutics Key News & Latest Developments
7.12 Silence Therapeutics
7.12.1 Silence Therapeutics Company Summary
7.12.2 Silence Therapeutics Business Overview
7.12.3 Silence Therapeutics RNA Therapeutics Major Product Offerings
7.12.4 Silence Therapeutics RNA Therapeutics Revenue in Global Market (2018-2023)
7.12.5 Silence Therapeutics Key News & Latest Developments
7.13 Astellas Pharma Inc.
7.13.1 Astellas Pharma Inc. Company Summary
7.13.2 Astellas Pharma Inc. Business Overview
7.13.3 Astellas Pharma Inc. RNA Therapeutics Major Product Offerings
7.13.4 Astellas Pharma Inc. RNA Therapeutics Revenue in Global Market (2018-2023)
7.13.5 Astellas Pharma Inc. Key News & Latest Developments
7.14 CureVac
7.14.1 CureVac Company Summary
7.14.2 CureVac Business Overview
7.14.3 CureVac RNA Therapeutics Major Product Offerings
7.14.4 CureVac RNA Therapeutics Revenue in Global Market (2018-2023)
7.14.5 CureVac Key News & Latest Developments
7.15 Sirnaomics
7.15.1 Sirnaomics Company Summary
7.15.2 Sirnaomics Business Overview
7.15.3 Sirnaomics RNA Therapeutics Major Product Offerings
7.15.4 Sirnaomics RNA Therapeutics Revenue in Global Market (2018-2023)
7.15.5 Sirnaomics Key News & Latest Developments
7.16 Arcturus Therapeutics
7.16.1 Arcturus Therapeutics Company Summary
7.16.2 Arcturus Therapeutics Business Overview
7.16.3 Arcturus Therapeutics RNA Therapeutics Major Product Offerings
7.16.4 Arcturus Therapeutics RNA Therapeutics Revenue in Global Market (2018-2023)
7.16.5 Arcturus Therapeutics Key News & Latest Developments
7.17 Arbutus Biopharma
7.17.1 Arbutus Biopharma Company Summary
7.17.2 Arbutus Biopharma Business Overview
7.17.3 Arbutus Biopharma RNA Therapeutics Major Product Offerings
7.17.4 Arbutus Biopharma RNA Therapeutics Revenue in Global Market (2018-2023)
7.17.5 Arbutus Biopharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. RNA Therapeutics Market Opportunities & Trends in Global Market
Table 2. RNA Therapeutics Market Drivers in Global Market
Table 3. RNA Therapeutics Market Restraints in Global Market
Table 4. Key Players of RNA Therapeutics in Global Market
Table 5. Top RNA Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global RNA Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global RNA Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies RNA Therapeutics Product Type
Table 9. List of Global Tier 1 RNA Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global RNA Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - RNA Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - RNA Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global RNA Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - RNA Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - RNA Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global RNA Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global RNA Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global RNA Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America RNA Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America RNA Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe RNA Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe RNA Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia RNA Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia RNA Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America RNA Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America RNA Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa RNA Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa RNA Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Moderna Company Summary
Table 31. Moderna RNA Therapeutics Product Offerings
Table 32. Moderna RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Moderna Key News & Latest Developments
Table 34. Alnylam Pharmaceuticals Company Summary
Table 35. Alnylam Pharmaceuticals RNA Therapeutics Product Offerings
Table 36. Alnylam Pharmaceuticals RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Alnylam Pharmaceuticals Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis RNA Therapeutics Product Offerings
Table 40. Novartis RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Ionis Pharmaceuticals Company Summary
Table 43. Ionis Pharmaceuticals RNA Therapeutics Product Offerings
Table 44. Ionis Pharmaceuticals RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Ionis Pharmaceuticals Key News & Latest Developments
Table 46. Sarepta Therapeutics Company Summary
Table 47. Sarepta Therapeutics RNA Therapeutics Product Offerings
Table 48. Sarepta Therapeutics RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Sarepta Therapeutics Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi RNA Therapeutics Product Offerings
Table 52. Sanofi RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer RNA Therapeutics Product Offerings
Table 56. Pfizer RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Arrowhead Pharmaceuticals Company Summary
Table 59. Arrowhead Pharmaceuticals RNA Therapeutics Product Offerings
Table 60. Arrowhead Pharmaceuticals RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Arrowhead Pharmaceuticals Key News & Latest Developments
Table 62. BioNTech Company Summary
Table 63. BioNTech RNA Therapeutics Product Offerings
Table 64. BioNTech RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. BioNTech Key News & Latest Developments
Table 66. Orna Therapeutics Company Summary
Table 67. Orna Therapeutics RNA Therapeutics Product Offerings
Table 68. Orna Therapeutics RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Orna Therapeutics Key News & Latest Developments
Table 70. CRISPR Therapeutics Company Summary
Table 71. CRISPR Therapeutics RNA Therapeutics Product Offerings
Table 72. CRISPR Therapeutics RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 73. CRISPR Therapeutics Key News & Latest Developments
Table 74. Silence Therapeutics Company Summary
Table 75. Silence Therapeutics RNA Therapeutics Product Offerings
Table 76. Silence Therapeutics RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 77. Silence Therapeutics Key News & Latest Developments
Table 78. Astellas Pharma Inc. Company Summary
Table 79. Astellas Pharma Inc. RNA Therapeutics Product Offerings
Table 80. Astellas Pharma Inc. RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 81. Astellas Pharma Inc. Key News & Latest Developments
Table 82. CureVac Company Summary
Table 83. CureVac RNA Therapeutics Product Offerings
Table 84. CureVac RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 85. CureVac Key News & Latest Developments
Table 86. Sirnaomics Company Summary
Table 87. Sirnaomics RNA Therapeutics Product Offerings
Table 88. Sirnaomics RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 89. Sirnaomics Key News & Latest Developments
Table 90. Arcturus Therapeutics Company Summary
Table 91. Arcturus Therapeutics RNA Therapeutics Product Offerings
Table 92. Arcturus Therapeutics RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 93. Arcturus Therapeutics Key News & Latest Developments
Table 94. Arbutus Biopharma Company Summary
Table 95. Arbutus Biopharma RNA Therapeutics Product Offerings
Table 96. Arbutus Biopharma RNA Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 97. Arbutus Biopharma Key News & Latest Developments
List of Figures
Figure 1. RNA Therapeutics Segment by Type in 2022
Figure 2. RNA Therapeutics Segment by Application in 2022
Figure 3. Global RNA Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global RNA Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global RNA Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by RNA Therapeutics Revenue in 2022
Figure 8. By Type - Global RNA Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global RNA Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global RNA Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global RNA Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global RNA Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global RNA Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global RNA Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America RNA Therapeutics Revenue Market Share, 2018-2029
Figure 16. US RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe RNA Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia RNA Therapeutics Revenue Market Share, 2018-2029
Figure 28. China RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America RNA Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa RNA Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE RNA Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Moderna RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Alnylam Pharmaceuticals RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Ionis Pharmaceuticals RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sarepta Therapeutics RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sanofi RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pfizer RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Arrowhead Pharmaceuticals RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. BioNTech RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Orna Therapeutics RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. CRISPR Therapeutics RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Silence Therapeutics RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Astellas Pharma Inc. RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. CureVac RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Sirnaomics RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Arcturus Therapeutics RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Arbutus Biopharma RNA Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • iPSC生成キットのグローバル市場展望 2023年-2029年：アルカリホスファターゼ染色法、多能性マーカー（タンパク質）、多能性マーカー（mRNA）
  • ヒトiPS細胞特性評価キットのグローバル市場展望 2023年-2029年：アルカリホスファターゼ染色法、多能性マーカー（タンパク質）、多能性マーカー（mRNA）
  • 免疫グロブリンG抗体治療薬のグローバル市場展望 2023年-2029年：IgG1、IgG4、その他
  • 慢性疲労症候群治療薬のグローバル市場展望 2023年-2029年：鎮痛剤・NSAID、抗うつ薬・抗精神病薬、抗菌薬・免疫調節薬
  • アルパース病治療のグローバル市場展望 2023年-2029年：言語療法、理学療法、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14460 )"RNA治療学のグローバル市場展望 2023年-2029年：mRNA、RNA干渉（RNAi）、アンチセンスオリゴヌクレオチド（ASO）、その他" (英文：RNA Therapeutics Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。